Dr. Johnston is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UC Department of Surgery
CARE/Crawley Building, Suite E-870 3230 Eden Avenue
Cincinnati, OH 45267Phone+1 513-558-7333
Summary
- Mike Johnston, MD is a Surgical Resident and Research Fellow who works with the University of Cincinnati and Cincinnati Children’s Hospital Medical Center for his surgical training and research fellowship in pediatric liver tumors.
Mike believes that through understanding the biochemical processes within pediatric liver tumors, hepatocellular carcinoma and hepatoblastoma, we can harness alternative chemotherapy regimens to aid in the treatment of cancer and reduce post-oncology treatment developmental delays. Additionally through advancing the cutting edge of surgery via research and advanced training, he knows we can continue to progress medicine and provide better care for patients.
Dr. Johnston landed his research experience at CCHMC where he has established subcutaneous and orthotropic patient derived xenograft models of hepatoblastoma and hepatocellular carcinoma. These are being utilized to research the biochemical effects of currently approved medications undergoing randomized control trials clinically. Additionally, he has been studying clinical surgical outcomes, establishing local tumor registries, and developing predictive models for patients.
Mike is an Ohio State Medical Board licensed physician, who received his Doctor of Medicine from the Indiana University School of Medicine in 2017. There he served as elected Class President for the largest medical school class in the nation and established local community development funds. He also received a merit based scholarship of $130,000 to cover his full medical school tuition. In residency he has now completed two years of training, where he was awarded the 2019 Department of Surgery Best Teaching Resident and has served as
the Department Medical Student Liaison.
Mike additionally holds a Bachelor of Science degree in Neurobiology and Physiology from Purdue University, where he also minored in Chemistry.
Education & Training
- University of Cincinnati Medical Center/College of MedicineResidency, Surgery, 2017 - 2024
- Indiana University School of MedicineClass of 2017
- Purdue UniversityBS, Neurobiology and Physiology, Deans List, 2009 - 2013
Certifications & Licensure
- OH State Medical License 2017 - 2023
Awards, Honors, & Recognition
- 2022 Arnold P. Gold Humanism and Excellence in Teaching Award Gold Humanism, 2022
- General Surgery Teaching Resident of the Year University of Cincinnati Medical Center, 2019
- Dean's Award: Outstanding Service in IUSM Dean’s Office Indiana University School of Medicine, 2017
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsNational trends for axillary lymph node dissection and survival outcomes for clinical T3/T4 node-negative breast cancer patients undergoing mastectomy with positive ly...Chantal Reyna, Michael E. Johnston, Mackenzie C. Morris, Tiffany C. Lee, Dennis J. Hanseman
Breast Cancer Research and Treatment. 2021-06-18 - 14 citationsHepatoblastomas exhibit marked NNMT downregulation driven by promoter DNA hypermethylation.Maria Prates Rivas, Talita Ferreira Marques Aguiar, Mariana Maschietto, Renan B. Lemes, Luiz Carlos Caires-Júnior
Tumour Biology. 2020-11-30 - 2 citationsGenetic Ablation of C/EBPα-p300 Pathway Blocks Development of Obese Pregnancy Associated Liver Disorders in Offspring.Margaret A Hanlon, Ruhi Gulati, Michael Johnston, Yasmeen Fleifil, Maria Rivas
Cellular and Molecular Gastroenterology and Hepatology. 2024-01-01
Journal Articles
- β-Catenin-Cancer-Enhancing Genomic Regions Axis is Involved in the Development of Fibrolamellar Hepatocellular Carcinoma1. Ruhi Gulati, Michael Johnston, Maria Rivas, … Nikolai Timchenko, Hepatology
- Commentary: PARP1 Activation Increases Expression of Modified Tumor Suppressors and Pathways Underlying Development of Aggressive HepatoblastomaMichael E. Johnston II, MD, Nikolai Timchenko, PhD, Communications Biology
- Surgical Oncology and Geriatric Patients.ME Johnston; JJ Sussman; SH Patel, Clinics of Geriatric Medicine, 2/1/2019
Books/Book Chapters
Press Mentions
- "Where are they now?"February 2nd, 2021
Grant Support
- Pediatric Liver Cancer (Nikolai Timchenko)NIHPresent
Research History
- Research FellowResearch Fellow in the Pediatric Liver Lab alongside Dr. Timchenko at CCHMC.2019 - 2021
Professional Memberships
- Member
- Member
- Association for Academic Surgery (AAS)Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: